Information about Meningococcal Conjugate Vaccine

Generic Name : Meningococcal Conjugate Vaccine
Up-to-date prescription details regarding Meningococcal Conjugate Vaccine are provided here.

Pronunciation : me NIN je KOK al KON je gate vax EEN

Learn the correct pronunciation of the Meningococcal Conjugate Vaccine, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings and its and its storage instructions.

You will also find a list of the medication's International and Indian brand or trade names, as well as its pricing information. For verification of the information presented on this page or for additional clarifications, it's advisable to consult your doctor.

ICD Code : Y58.9 Therapeutic Classification : Immunizing Agents

Trade Names/Brand Names of Meningococcal Conjugate Vaccine

International :

Menactra, Menveo

Why is Meningococcal Conjugate Vaccine Prescribed? (Indications)

This medication is a vaccine, prescribed for bacterial infections (Neisseria meningitidis).

When should Meningococcal Conjugate Vaccine not be taken? (Contraindications)

Contraindicated in patients with nervous system problem (Guillain-Barr syndrome), and hypersensitivity.

What is the dosage of Meningococcal Conjugate Vaccine?

IM- Child: 2-10 months: 2 doses, 2 months apart. Additional booster dose at 12-15 months old but must be at least 2 months from the previous dose. 11-14 months: 2 doses, 2 months apart. 15-71 months: Single dose.

How should Meningococcal Conjugate Vaccine be taken?

It comes as a solution for injection to be administered by a healthcare provider into the large muscle.

What are the warnings and precautions for Meningococcal Conjugate Vaccine?

• Caution should be exercised in patients with history of poor immunity, undergoing chemotherapy, radiation therapy, any allergy, who are taking other medications, elderly, during pregnancy and breastfeeding.

• It should not be used in children less than 9 years.